HTA7 Access to Pan-Tumor Therapies in Oncology – Do US Patients Have an Advantage?

Abstract

Authors

H Davis S Ferguson C Solon

Full Text Cite This Article
Back to Volume 27, Supplemental Issue 6S
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×